Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Rossi P. Naoumova"'
Autor:
Stuart D. Horswell, Lee G.D. Fryer, Claire E. Hutchison, Dlear Zindrou, Helen E. Speedy, Margaret-M. Town, Emma J. Duncan, Rasheeta Sivapackianathan, Hetal N. Patel, Emma L. Jones, Adam Braithwaite, Max P.A. Salm, Claire K.Y. Neuwirth, Elizabeth Potter, Jonathan R. Anderson, Kenneth M. Taylor, Mary Seed, D. John Betteridge, Martin A. Crook, Anthony S. Wierzbicki, James Scott, Rossi P. Naoumova, Carol C. Shoulders
Publikováno v:
Journal of Lipid Research, Vol 54, Iss 12, Pp 3491-3505 (2013)
The purpose of this study was to determine the core biological processes perturbed in the subcutaneous adipose tissue of familial combined hyperlipidemia (FCHL) patients. Annotation of FCHL and control microarray datasets revealed a distinctive FCHL
Externí odkaz:
https://doaj.org/article/099d6a65d00b49c4bdc385821c579ab0
Autor:
Carol C. Shoulders, Xia Yang, Stuart Horswell, William O.C.M. Cookson, Eric E. Schadt, Claire E. Hutchison, Helen E. Speedy, M. Salm, Rossi P. Naoumova, Liming Liang, Anthony S. Wierzbicki
Publikováno v:
Genome Research. 22:1144-1153
Genomic inversions are an increasingly recognized source of genetic variation. However, a lack of reliable high-throughput genotyping assays for these structures has precluded a full understanding of an inversion's phylogenetic, phenotypic, and popul
Autor:
Isabella Tosi, Rossi P. Naoumova, Joseph V. Hajnal, Elizabeth Potter, Stephan A. Schmitz, Julie Fitzpatrick, Declan P. O'Regan, Clare Neuwirth
Publikováno v:
Journal of Vascular and Interventional Radiology. 19:1403-1408
To compare the aortic plaque burden in patients with heterozygous familial hypercholesterolemia on long-term statin treatment with that of matched control subjects.The authors studied 11 heterozygous, nonsmoking, nondiabetic, and nonhypertensive pati
Autor:
Joseph V. Hajnal, Julie Fitzpatrick, Marzena Wylezinska-Arridge, Rossi P. Naoumova, Martina F. Callaghan, Stephan A. Schmitz, Declan P. O'Regan
Publikováno v:
Radiology. 247:550-557
Research ethics committee approval was obtained for this study, and written informed consent was obtained from all participants. The purpose was to prospectively evaluate the feasibility of breath-hold multiecho in- and out-of-phase magnetic resonanc
Autor:
Joseph V. Hajnal, Martina F. Callaghan, Stephan A. Schmitz, Julie Fitzpatrick, Declan P. O'Regan, Rossi P. Naoumova
Publikováno v:
European Radiology. 18:800-805
This study was designed to assess whether breath-hold cardiac multiecho imaging at 3.0 T is achievable without significant image artefacts and if fat/water phase interference modulates the exponential T2* signal decay. Twelve healthy volunteers (mean
Autor:
Marco Mongillo, Mary Seed, Rossi P. Naoumova, John Betteridge, Heiko Kindler, Muhammad Tahir Khan, Lucia Leccisotti, Paolo G. Camici, Clare Neuwirth, Paul Holvoet
Publikováno v:
Journal of the American College of Cardiology. 50:2051-2058
Objectives This study’s aim was to examine whether treatment with pioglitazone, added to conventional lipid-lowering therapy, would improve myocardial glucose utilization (MGU) and blood flow (MBF) in nondiabetic patients with familial combined hyp
Autor:
Mary Seed, Elizabeth Potter, Robert Hughes, Christopher North, Jimmy D. Bell, Julie Fitzpatrick, Isabella Tosi, Gavin Hamilton, Paul Holvoet, Vian Amber, E. Louise Thomas, Rossi P. Naoumova, D. John Betteridge
Publikováno v:
Atherosclerosis. 195:e181-e190
Familial combined hyperlipidaemia (FCHL) is a complex genetic disorder conferring high risk of premature atherosclerosis, characterized by high cholesterol and/or triglyceride, low high density lipoprotein (HDL) cholesterol and insulin resistance. We
Publikováno v:
Atherosclerosis. 194:102-111
Familial hypercholesterolaemia (FH) results from defective catabolism of low density lipoproteins (LDL), leading to premature atherosclerosis and early coronary heart disease. It is commonly caused by mutations in LDLR , encoding the LDL receptor tha
Autor:
Mary Seed, Gilbert R. Thompson, Shahenaz Walji, James Scott, Anne K. Soutar, Nicolas B. Myant, Timothy J. Aitman, Clare Neuwirth, Rossi P. Naoumova
Background and aims There is a paucity of data concerning the influence of lipid-lowering therapy on cardiovascular (CV) outcomes in patients with homozygous familial hypercholesterolaemia (FH). To redress this a retrospective analysis was undertaken
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9886995ea5c696a063b6e8f86706fc96
http://hdl.handle.net/10044/1/64546
http://hdl.handle.net/10044/1/64546
Autor:
Charles van Heyningen, Anne K. Soutar, Isabella Tosi, Rossi P. Naoumova, Dilip D. Patel, Stuart Horswell, Clare Neuwirth, A. David Marais
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 25:2654-2660
Objective— Analysis of long-term (30 years) clinical history and response to treatment of 13 patients with the D374Y mutation of PCSK9 (PCSK9 patients) from 4 unrelated white British families compared with 36 white British patients with heterozygou